Daryl focuses on representing life sciences and technology companies in a broad range of cross-border intellectual property-driven transactions, including strategic M&A, joint ventures, complex licensing, collaborative arrangements and other commercial transactions. He earned BS and PhD degrees from Brigham Young University, conducted postdoctoral research at the University of Illinois in Champaign in immunogenetics, and earned a JD from Columbia University.
-
Clifford Chance advised TRU Simulation + Training on its joint venture with FlightSafety International
5 April 2019
Client Work -
Clifford Chance advises private equity firm OpCapita on its acquisition of a majority stake in US retailer Maurices
25 March 2019
Client Work -
Clifford Chance advises Merck on global strategic immuno-oncology alliance with GlaxoSmithKline
5 February 2019
Client Work -
Clifford Chance Advising Symrise on Purchase of ADF/IDF
1 February 2019
Client Work -
Clifford Chance advises Euromoney on its acquisition of BoardEx and The Deal from TheStreet, a US public company
6 December 2018
Client Work
Contact details
- Clifford Chance, New York
- +12128784960
- Email me
- Save my Vcard
- Practice area Intellectual property, M&A corporate
- Sector Consumer goods & retail, Healthcare, life sciences & chemicals, Medical devices healthcare equipment, Telecommunications, media & technology, Industrials, Healthcare providers, Pharmaceuticals, Transport & logistics
Global M&A 
Financial Markets Toolkit
Talking Tech
Online Services Portal
Brexit Hub